首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   15648篇
  免费   1391篇
  国内免费   8篇
  2021年   207篇
  2020年   110篇
  2019年   171篇
  2018年   177篇
  2017年   155篇
  2016年   320篇
  2015年   518篇
  2014年   593篇
  2013年   794篇
  2012年   968篇
  2011年   954篇
  2010年   624篇
  2009年   577篇
  2008年   819篇
  2007年   846篇
  2006年   740篇
  2005年   804篇
  2004年   773篇
  2003年   697篇
  2002年   683篇
  2001年   194篇
  2000年   171篇
  1999年   189篇
  1998年   213篇
  1997年   143篇
  1996年   136篇
  1995年   119篇
  1994年   116篇
  1993年   109篇
  1992年   152篇
  1991年   124篇
  1990年   120篇
  1989年   121篇
  1988年   108篇
  1987年   121篇
  1986年   130篇
  1985年   119篇
  1984年   166篇
  1983年   129篇
  1982年   146篇
  1981年   149篇
  1980年   169篇
  1979年   137篇
  1978年   127篇
  1977年   125篇
  1976年   107篇
  1975年   107篇
  1974年   118篇
  1973年   95篇
  1972年   83篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications) and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering.  相似文献   
2.
3.
4.
5.
6.
Summary Leaf chemistry of a willow clone (Salix aquatica Smith) differed significantly when grown at constant relative growth rates depending upon the relative availability of nutrients and light. Concentration of amino acids and nitrate were high in plants grown with a relative surplus of nutrients. Concentrations of starch, tannin, and lignin, on the other hand, were high in plants grown with a relative surplus of carbon. Photosynthetic rates, expressed per unit leaf area, were similar when plants were grown under high light conditions, regardless of nutrient availability. Dark respiration was much higher in plants supplied with abundant nutrients than in those with a more limited supply, reflecting differences in nitrogen concentration of the tissue. The experimental approach allows plants to be grown to a standard size with differing, but highly uniform chemistry. Plants grown in such a manner may provide good experimental material to evaluate interactions between herbivores or pathogens and their hosts.  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号